Potential-dependent membrane permeabilization and mitochondrial aggregation caused by anticancer polyarginine-KLA peptides

Archives of Biochemistry and Biophysics

Volumn 493, Issue 2, 2010, Pages 213-220

  Lemeshko, Victor V ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Apoptosis; Cancer; Membrane permeabilization; Membrane potential; Mitochondrial aggregation; NADH oxidation; Polycationic peptides

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; ARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYL GLYCYLGLYCYL LYSYLLEUCYLALANYLLYSYLLEUCYLALANYLLYSYLLYSYLLEUCYLALANYLLYSYLLEUCYLALANYLLYSINE POLYPEPTIDE; DEXTRO ARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYL GLYCYLGLYCYL LYSYLLEUCYLALANYLLYSYLLEUCYLALANYLLYSYLLYSYLLEUCYLALANYLLYSYLLEUCYLALANYLLYSINE POLYPEPTIDE; POLYARGININE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL AGGREGATION; CELL METABOLISM; CELL PERMEABILIZATION; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG MECHANISM; ERYTHROCYTE MEMBRANE; GENE VECTOR; LIVER MITOCHONDRION; MALE; METABOLIC INHIBITION; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANES; PEPTIDES; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 73149094278     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2009.11.004     Document Type: Article

References (64)

1. Zasloff M. Nature 415 (2002) 389-395
2. Jenssen H., Hamill P., and Hancock R.E. Clin. Microbiol. Rev. 19 (2006) 491-511
3. Mookherjee N., and Hancock R.E. Cell. Mol. Life Sci. 64 (2007) 922-933
4. Sorensen O.E., Borregaard N., and Cole A.M. Contrib. Microbiol. 15 (2008) 61-77
5. Epand R.M., and Epand R.F. Biochim. Biophys. Acta 1788 (2009) 289-294
6. Cruciani R.A., Barker J.L., Zasloff M., and Chen H.C. Proc. Natl. Acad. Sci. USA 88 (1991) 3792-3796
7. Baker M.A., Maloy W.L., Zasloff M., and Jacob L.S. Cancer Res. 53 (1993) 3052-3057
8. Chen H.M., Wang W., Smith D., and Chan S.C. Biochim. Biophys. Acta 1336 (1997) 171-179
9. Moon D.O., Park S.Y., Choi Y.H., Kim N.D., Lee C., and Kim G.Y. Toxicon 51 (2008) 112-120
10. Hoskin D.W., and Ramamoorthy A. Biochim. Biophys. Acta 1778 (2008) 357-375
11. Palffy R., Gardlik R., Behuliak M., Kadasi L., Turna J., and Celec P. Mol. Med. 15 (2009) 51-59
12. Javadpour M.M., Juban M.M., Lo W.C., Bishop S.M., Alberty J.B., Cowell S.M., Becker C.L., and McLaughlin M.L. J. Med. Chem. 39 (1996) 3107-3113
13. Chen Y., Vasil A.I., Rehaume L., Mant C.T., Burns J.L., Vasil M.L., Hancock R.E., and Hodges R.S. Chem. Biol. Drug Des. 67 (2006) 162-173
14. Glukhov E., Burrows L.L., and Deber C.M. Biopolymers 89 (2008) 360-371
15. Park S.C., Kim M.H., Hossain M.A., Shin S.Y., Kim Y., Stella L., Wade J.D., Park Y., and Hahm K.S. Biochim. Biophys. Acta 1778 (2008) 229-241
16. Zasloff M. Proc. Natl. Acad. Sci. USA 84 (1987) 5449-5453
17. Bessalle R., Kapitkovsky A., Gorea A., Shalit I., and Fridkin M. FEBS Lett. 274 (1990) 151-155
18. Hultmark D., Steiner H., Rasmuson T., and Boman H.G. Eur. J. Biochem. 106 (1980) 7-16
19. Javadpour M.M., and Barkley M.D. Biochemistry 36 (1997) 9540-9549
20. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Rio G.D., Krajewski S., Lombardo C.R., Rao R., Ruoslahti E., Bredesen D.E., and Pasqualini R. Nat. Med. 5 (1999) 1032-1038
21. Mai J.C., Mi Z., Kim S.H., Ng B., and Robbins P.D. Cancer Res. 61 (2001) 7709-7712
22. Law B., Quinti L., Choi Y., Weissleder R., and Tung C.H. Mol. Cancer Ther. 5 (2006) 1944-1949
23. Kelly K.A., and Jones D.A. Neoplasia 5 (2003) 437-444
24. Marks A.J., Cooper M.S., Anderson R.J., Orchard K.H., Hale G., North J.M., Ganeshaguru K., Steele A.J., Mehta A.B., Lowdell M.W., and Wickremasinghe R.G. Cancer Res. 65 (2005) 2373-2377
25. Rege K., Patel S.J., Megeed Z., and Yarmush M.L. Cancer Res. 67 (2007) 6368-6375
26. Mi Z., Mai J., Lu X., and Robbins P.D. Mol. Ther. 2 (2000) 339-347
27. Lemeshko V.V., Solano S., Lopez L.F., Rendón D.A., Ghafourifar P., and Gomez L.A. Arch. Biochem. Biophys. 412 (2003) 176-185
28. Lemeshko V.V., Lopez L.F., Solano S., and Torres R. Antioxid. Redox Signal. 5 (2003) 281-290
29. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., and Steinman L. Proc. Natl. Acad. Sci. USA 97 (2000) 13003-13008
30. Tung C.H., and Weissleder R. Adv. Drug Deliv. Rev. 55 (2003) 281-294
31. Lemeshko V.V., Arias M., and Orduz S. J. Biol. Chem. 280 (2005) 15579-15586
32. V.V. Lemeshko, F. Guzman, M.E. Patarroyo, C. Segura, S. Orduz, U. S. Patent No. 7,041,647, May 9, 2006.
33. Segura C., Guzmán F., Salazar L.M., Patarroyo M.E., Orduz S., and Lemeshko V.V. Biochem. Biophys. Res. Commun. 353 (2007) 908-914
34. Arias M., Orduz S., and Lemeshko V.V. Biochim. Biophys. Acta 1788 (2009) 532-537
35. Glukhov E., Stark M., Burrows L.L., and Deber C.M. J. Biol. Chem. 280 (2005) 33960-33967
36. Lemeshko V.V. J. Biol. Chem. 277 (2002) 17751-17757
37. Lemeshko V.V. 52nd Biophysical society meeting. Biophys. J. 94 2S (2008) 1028-1029
38. Lemeshko V.V. Experimental biology 2009 meeting. FASEB J. 23 (2009) LB230
39. Houghten R.A. Proc. Natl. Acad. Sci. USA 82 (1985) 5131-5135
40. Tam J.P., Heath W.F., and Merrifield R.B. J. Am. Chem. Soc. 105 (1983) 6442-6455
41. Lemeshko V.V., and Kugler W. J. Biol. Chem. 282 (2007) 37303-37307
42. Lemeshko V.V. Arch. Biochem. Biophys. 388 (2001) 60-66
43. Wieckowski M.R., and Wojtczak L. FEBS Lett. 423 (1998) 339-342
44. Shapiro H.M. Methods 21 (2000) 271-279
45. Lemeshko V.V., and Haridas V. Arch. Biochem. Biophys. 454 (2006) 114-122
46. Mikkelsen R.B., Tanabe K., and Wallace D.F.H. J. Cell Biol. 93 (1982) 685-689
47. Costantini P., Jacotot E., Decaudin D., and Kroemer G. J. Natl. Cancer Inst. 92 (2000) 1042-1053
48. Don A.S., and Hogg P.J. Trends Mol. Med. 10 (2004) 372-378
49. Hail Jr. N. Apoptosis 10 (2005) 687-705
50. Dias N., and Bailly C. Biochem. Pharmacol. 70 (2005) 1-12
51. Armstrong J.S. Antioxid. Redox Signal. 10 (2008) 575-578
52. Horton K.L., Stewart K.M., Fonseca S.B., Guo Q., and Kelley S.O. Chem. Biol. 15 (2008) 375-382
53. Gogvadze V., Orrenius S., and Zhivotovsky B. Apoptosis 14 (2009) 624-640
54. Desoize B. Anticancer Res. 14 (1994) 2291-2294
55. Gogvadze V., Orrenius S., and Zhivotovsky B. Trends Cell Biol. 18 (2008) 165-173
56. Wang K.R., Yan J.X., Zhang B.Z., Song J.J., Jia P.F., and Wang R. Cancer Lett. 278 (2009) 65-72
57. Horton K.L., and Kelley S.O. J. Med. Chem. 52 (2009) 3293-3299
58. Moss T.N., Vo A., McKeehan W.L., and Liu L. In Vitro Cell Dev. Biol. Anim. 43 (2007) 139-146
59. Haga N., Fujita N., and Tsuruo T. Oncogene 22 (2003) 5579-5585
60. Haga N., Fujita N., and Tsuruo T. Cancer Sci. 96 (2005) 825-833
61. Huang P., Yu T., and Yoon Y. Eur. J. Cell Biol. 86 (2007) 289-302
62. Finucane D.M., Waterhouse N.J., Amarante-Mendes G.P., Cotter T.G., and Green D.R. Exp. Cell Res. 251 (1999) 166-174
63. Bernardi P., and Azzone G.F. J. Biol. Chem. 256 (1981) 7187-7192
64. Chen L.B. Ann. Rev. Cell Biol. 4 (1988) 155-181